Cinclus Pharma Holding AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	874	995	-	-	-	-	Upgrade
Enterprise Value	342	351	-	-	-	-	Upgrade
Last Close Price	18.78	21.38	-	-	-	-	Upgrade
PS Ratio	18.05	217.24	-	-	-	-	Upgrade
PB Ratio	2.03	1.79	-	-	-	-	Upgrade
P/TBV Ratio	2.03	1.79	-	-	-	-	Upgrade
EV/Sales Ratio	7.07	76.67	-	-	-	-	Upgrade
Debt / Equity Ratio	0.02	0.00	-1.71	0.00	0.01	-	Upgrade
Asset Turnover	0.08	0.01	0.04	0.06	-	-	Upgrade
Quick Ratio	5.72	12.62	0.56	3.99	7.17	32.17	Upgrade
Current Ratio	6.08	13.20	0.57	4.01	7.47	32.74	Upgrade
Return on Equity (ROE)	-34.17%	-70.23%	-859.20%	-196.14%	-45.79%	-39.33%	Upgrade
Return on Assets (ROA)	-19.44%	-30.36%	-89.35%	-79.11%	-29.29%	-21.50%	Upgrade
Return on Invested Capital (ROIC)	-23.17%	-34.63%	-137.82%	-102.90%	-31.49%	-22.49%	Upgrade
Return on Capital Employed (ROCE)	-39.30%	-30.40%	286.10%	-150.90%	-66.00%	-19.10%	Upgrade
Earnings Yield	-20.26%	-16.89%	-	-	-	-	Upgrade
FCF Yield	-11.85%	-17.93%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-45.70%	-41.26%	-13.81%	-9.26%	-8415.70%	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.